Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Modeling embryonic heart vascular plexus development and sympathetic innervation on a human heart organoid.

iScience·2026

Same author

Bioreactor expansion of human neural progenitor cells for exosome scalable production and miRNA-engineering.

Journal of biological engineering·2026

Same author

Continuous Production of Highly Functional Vascularized Hepatobiliary Organoids from Human Pluripotent Stem Cells using a Scalable Microfluidic Platform.

Advanced functional materials·2025

Same author

The cytotoxicity of synthetic cathinones on dopaminergic-differentiated SH-SY5Y neuroblastoma cell line: Exploring the role of β-keto metabolic reduction.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2025

Same author

Continuous collection of human mesenchymal-stromal-cell-derived extracellular vesicles from a stirred tank reactor operated under xenogeneic-free conditions for therapeutic applications.

Stem cell research & therapy·2025

Same author

Patient-derived induced pluripotent stem cells to study non-canonical splicing variants associated with Hypertrophic Cardiomyopathy.

Stem cell research·2024

Same journal

Bacterial spores as a modular platform for the production of amyloids for materials.

Trends in biotechnology·2026

Same journal

The oriGen case and Mexico's regulatory blind spots in genomic biobanking.

Trends in biotechnology·2026

Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026

Same journal

Over 4 months of ethylene production using solid-state photosynthetic cell factories.

Trends in biotechnology·2026

Same journal

Closing the nitrogen loop in groundwater with biohybrid technologies.

Trends in biotechnology·2026

Same journal

Engineering environmental bacteria for whole-cell PET hydrolysis and assimilation.

Trends in biotechnology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Nov 17, 2025

Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform

Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform

Published on: May 17, 2021

Modeling the Human Body on Microfluidic Chips.

Sasan Jalili-Firoozinezhad¹, Cláudia C Miranda², Joaquim M S Cabral²

¹Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Trends in Biotechnology

|February 14, 2021

Summary

This summary is machine-generated.

Organ-on-chip technology creates functional human body-on-chip platforms for advanced in vitro research. This approach enhances disease modeling, drug development, and personalized medicine, overcoming limitations of traditional models.

Keywords:

disease modeling drug discovery in vitro models microphysiological systems organ-on-chip personalized medicine

More Related Videos

Modeling the Endothelial Glycocalyx Post-Pneumonectomy in a 3D Fluidic Chip - An Approach to Fabricating a Vascular-based Organ-on-Chip System

Modeling the Endothelial Glycocalyx Post-Pneumonectomy in a 3D Fluidic Chip - An Approach to Fabricating a Vascular-based Organ-on-Chip System

Published on: September 16, 2025

Microfluidic Chips Controlled with Elastomeric Microvalve Arrays

Microfluidic Chips Controlled with Elastomeric Microvalve Arrays

Published on: October 1, 2007

Related Experiment Videos

Last Updated: Nov 17, 2025

Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform

Generation of a Simplified Three-Dimensional Skin-on-a-chip Model in a Micromachined Microfluidic Platform

Published on: May 17, 2021

Modeling the Endothelial Glycocalyx Post-Pneumonectomy in a 3D Fluidic Chip - An Approach to Fabricating a Vascular-based Organ-on-Chip System

Modeling the Endothelial Glycocalyx Post-Pneumonectomy in a 3D Fluidic Chip - An Approach to Fabricating a Vascular-based Organ-on-Chip System

Published on: September 16, 2025

Microfluidic Chips Controlled with Elastomeric Microvalve Arrays

Microfluidic Chips Controlled with Elastomeric Microvalve Arrays

Published on: October 1, 2007

Area of Science:

Biomedical Engineering
Translational Medicine
In Vitro Modeling

Background:

Traditional animal models and in vitro systems inadequately replicate human physiology and disease.
Existing models fail to accurately predict drug toxicity and efficacy in humans.
There is a critical need for more human-relevant experimental systems.

Purpose of the Study:

To highlight the advantages and translational potential of human body-on-chip platforms.
To explore the application of body-on-chip technology in disease modeling, drug development, and personalized medicine.
To identify current limitations and propose future directions for body-on-chip technology.

Main Methods:

Linking multiple organ-on-chip models to create a multi-organ system.
Utilizing advanced cell culture and microfluidic technologies.
Developing a functional in vitro human body model.

Main Results:

Body-on-chip platforms offer a more accurate recapitulation of human physiology and pathophysiology compared to traditional models.
These platforms demonstrate significant potential for improving the prediction of drug responses and toxicities.
The technology facilitates the study of complex, multi-organ interactions in a controlled in vitro environment.

Conclusions:

Human body-on-chip platforms represent a significant advancement in in vitro research, bridging the gap between traditional models and human experimentation.
This technology holds immense promise for accelerating therapeutic development and enabling personalized medicine strategies.
Addressing current limitations through innovative approaches will further unlock the full translational potential of body-on-chip systems.